Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2019 May 30;28(8):1353–1363. doi: 10.1158/1055-9965.EPI-18-0872

Table 3:

Male and Female Hispanic Cancer Statistics by cancer site: age-adjusted average annual mortality rate (AMR) per 100,000 person-years and standardized mortality ratios (SMRs), 2003-2012.

MALES NON-HISPANIC WHITE ALL HISPANIC MEXICAN CUBAN PUERTO RICAN CENTRAL or SOUTH AMERICAN
Cancer Site n AMR1 (95% CI) SMR2 n AMR1 (95% CI) SMR2 n AMR1 (95% CI) SMR2 n AMR1 (95% CI) SMR2 n AMR1 (95% CI) SMR2 n AMR1 (95% CI) SMR2
All Sites 2389032 220.42 (220.14-220.71) 1 151385 153.68 (152.84-154.53) 0.69 (0.69-0.69) 83236 154.72 (153.55-155.89) 0.69 (0.69-0.69) 16570 178.62 (175.89-181.36) 0.81 (0.8-0.82) 19034 179.73 (176.92-182.54) 0.84 (0.82-0.85) 10521 91.19 (89.09-93.29) 0.4 (0.39-0.41)
Lung 736913 66.69 (66.54-66.85) 1 29246 31.73 (31.34-32.12) 0.44 (0.44-0.45) 14634 30.51 (29.98-31.04) 0.41 (0.4-0.41) 4737 50.26 (48.82-51.69) 0.75 (0.73-0.78) 3969 37.59 (36.32-38.85) 0.57 (0.55-0.59) 1546 14.63 (13.79-15.47) 0.20 (0.10-0.21)
Prostate 218687 21.68 (21.59-21.77) 1 14212 19.1 (18.77-19.43) 0.89 (0.88-0.91) 7361 18.69 (18.25-19.14) 0.87 (0.85-0.89) 1929 21.51 (20.54-22.47) 1 (0.95-1.04) 1651 21.32 (20.23-22.42) 1 (0.95-1.05) 1038 13.95 (13.02-14.88) 0.64 (0.60-0.68)
Colon and rectum 213040 19.74 (19.65-19.82) 1 15892 16.06 (15.79-16.34) 0.81 (0.79-0.82) 8670 15.86 (15.49-16.23) 0.8 (0.79-0.82) 1813 19.54 (18.64-20.44) 1 (0.95-1.04) 2033 19.8 (18.85-20.75) 1 (0.96-1.05) 969 7.81 (7.22-8.41) 0.41 (0.38-0.44)
Pancreas 139941 12.66 (12.59-12.73) 1 9714 9.72 (9.51-9.93) 0.75 (0.74-0.77) 5355 9.81 (9.52-10.1) 0.76 (0.74-0.78) 1057 11.28 (10.6-11.96) 0.89 (0.84-0.95) 1092 10.01 (9.36-10.66) 0.81 (0.76-0.86) 711 6.3 (5.75-6.84) 0.46 (0.42-0.49)
Liver 81255 7.17 (7.12-7.22) 1 13850 12.45 (12.22-12.68) 1.7 (1.67-1.73) 8397 14.01 (13.68-14.34) 1.86 (1.82-1.9) 720 7.68 (7.12-8.25) 1.07 (0.99-1.15) 2123 16.71 (15.94-17.48) 2.51 (2.41-2.62) 763 6.13 (5.62-6.65) 0.75 (0.69-0.8)
Stomach 43192 4 (3.96-4.04) 1 7996 7.79 (7.6-7.98) 1.97 (1.93-2.02) 4610 8.15 (7.89-8.42) 2.07 (2.01-2.13) 429 4.67 (4.22-5.11) 1.16 (1.05-1.27) 834 8.41 (7.78-9.03) 2 (1.86-2.14) 965 7.58 (7-8.16) 1.97 (1.84-2.09)
Leukemia 105913 10.09 (10.03-10.16) 1 7615 6.28 (6.12-6.44) 0.74 (0.72-0.76) 4462 6.19 (5.97-6.41) 0.78 (0.75-0.8) 645 7.07 (6.52-7.62) 0.7 (0.65-0.75) 764 6.7 (6.16-7.24) 0.74 (0.68-0.79) 712 4.81 (4.36-5.27) 0.6 (0.55-0.64)
NHL 94053 8.84 (8.78-8.9) 1 6725 6.54 (6.36-6.71) 0.78 (0.76-0.8) 3769 6.77 (6.52-7.01) 0.79 (0.77-0.82) 619 6.72 (6.19-7.25) 0.76 (0.7-0.82) 817 7.31 (6.75-7.86) 0.92 (0.86-0.99) 632 4.97 (4.49-5.45) 0.62 (0.57-0.67)
FEMALES NHW ALL HISPANIC MEXICAN CUBAN PUERTO RICAN CENTRAL or SOUTH AMERICAN
Site n AMR1 (95% CI) SMR2 n AMR1 (95% CI) SMR2 n AMR1 (95% CI) SMR2 n AMR1 (95% CI) SMR2 n AMR1 (95% CI) SMR2 n AMR1 (95% CI) SMR2
All Sites 183994 157.33 (156.59-158.07) 1 38978 106.49 (105.39-107.59) 0.69 (0.68-0.69) 72657 107.33 (106.51-108.15) 0.7 (0.69-0.7) 12559 103.87 (102.01-105.73) 0.67 (0.66-0.68) 16327 111.41 (109.64-113.17) 0.72 (0.71-0.73) 12873 69.715 (68.42-71.01) 0.44 (0.44-0.45)
Breast 597825 23.11 (23.02-23.19) 1 21651 15.05 (14.84-15.26) 0.67 (0.66-0.68) 11572 15.28 (14.99-15.58) 0.69 (0.68-0.7) 2026 17.56 (16.78-18.34) 0.76 (0.73-0.79) 2684 17.02 (16.36-17.69) 0.75 (0.72-0.78) 1947 9.11 (8.67-9.54) 0.41 (0.39-0.43)
Lung 319254 23.11 (23.02-23.19) 1 17662 14.32 (14.1-14.53) 0.32 (0.32-0.33) 8647 14.35 (14.03-14.66) 0.31 (0.31-0.32) 1947 16.05 (15.32-16.78) 0.38 (0.36-0.39) 2498 17.49 (16.78-18.19) 0.4 (0.39-0.42) 1366 8.12 (7.66-8.57) 0.17 (0.16-0.18)
Colon and rectum 206599 14.06 (14-14.12) 1 13088 10.34 (10.16-10.52) 0.74 (0.72-0.75) 6252 9.7 (9.45-9.95) 0.7 (0.68-0.72) 1680 13.36 (12.71-14.01) 0.95 (0.91-1) 1880 13.34 (12.72-13.96) 0.96 (0.91-1) 1077 6.16 (5.77-6.56) 0.44 (0.41-0.46)
Pancreas 137154 9.46 (9.41-9.52) 1 9560 7.82 (7.65-7.98) 0.81 (0.79-0.82) 5075 8.34 (8.1-8.57) 0.86 (0.83-0.88) 982 7.68 (7.19-8.17) 0.83 (0.78-0.88) 1022 7.41 (6.94-7.87) 0.77 (0.72-0.82) 931 5.7 (5.32-6.09) 0.56 (0.53-0.6)
Ovary 42249 2.97 (2.94-3) 1 7933 5.87 (5.74-6.01) 0.67 (0.66-0.69) 4311 6.24 (6.04-6.44) 0.72 (0.69-0.74) 683 5.86 (5.41-6.31) 0.66 (0.61-0.71) 810 5.5 (5.11-5.89) 0.62 (0.57-0.66) 818 4.1 (3.79-4.4) 0.48 (0.45-0.51)
Liver 29096 2.01 (1.99-2.03) 1 6877 5.52 (5.38-5.65) 1.78 (1.74-1.83) 4122 6.65 (6.44-6.87) 2.11 (2.05-2.17) 458 3.6 (3.26-3.93) 1.27 (1.15-1.38) 713 4.95 (4.58-5.32) 1.67 (1.54-1.79) 639 3.84 (3.53-4.16) 1.18 (1.09-1.27)
Stomach 79045 5.56 (5.52-5.6) 1 6015 4.46 (4.34-4.58) 2.33 (2.28-2.39) 3415 4.92 (4.74-5.09) 2.62 (2.53-2.71) 260 2.1 (1.84-2.36) 1.04 (0.91-1.17) 565 4.04 (3.69-4.38) 1.99 (1.83-2.16) 922 4.73 (4.4-5.06) 2.57 (2.4-2.73)
Leukemia 121526 8.72 (8.67-8.77) 1 5999 4.03 (3.92-4.14) 0.8 (0.78-0.82) 3308 3.99 (3.84-4.14) 0.85 (0.82-0.88) 547 4.54 (4.15-4.94) 0.8 (0.73-0.87) 641 4.17 (3.83-4.5) 0.79 (0.73-0.86) 622 3.12 (2.86-3.39) 0.62 (0.57-0.67)
NHL 80204 5.47 (5.43-5.51) 1 5599 4.44 (4.32-4.56) 0.83 (0.81-0.85) 3007 4.75 (4.57-4.93) 0.89 (0.86-0.92) 556 4.51 (4.12-4.89) 0.8 (0.73-0.86) 617 4.33 (3.98-4.69) 0.83 (0.76-0.89) 585 3.49 (3.19-3.79) 0.64 (0.59-0.69)
1.

Average annual mortality rates (AMRs) are reported per 100,000 person-years. The numerator of the rate was determined by the total number of cancer deaths over the 10-year period in each sex-, Hispanic group- and site-specific stratum. The denominator is the 10-year sum of the sex- and Hispanic group-specific U.S population based on census data. Rates were directly standardized to the 2000 U.S. population age distribution to render them comparable across stratum.

2.

Standardized mortality ratios (SMRs) were created by dividing the sum of the 10-year sex-, Hispanic group- and site-specific deaths by the “expected” number of deaths, as defined by the sum of the 10-year deaths for the sex- and site-specific NHW population (the reference population).